Consumer Discretionary • Professional Services
$36.62 ▼ -0.05
(-0.14%)
MKT CAP: $1.82B • VOL: 256.2K
52W L $18 52W H $52
ASTH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.18B | $2.03B | $1.39B |
| YoY Revenue Growth % | +56.4% | +46.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $78.5M | $89.3M | $84.6M |
| Operating Margin % | 2.5% | 4.4% | 6.1% |
| Net Income (GAAP) | $24.0M | $50.0M | $58.0M |
| EBITDA (Normalized) | $86.6M | $95.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $114.6M | $52.2M | $68.2M |
| Capital Expenditures (CapEx) | $10.1M | $8.0M | — |
| Free Cash Flow (FCF) | $104.5M | $44.2M | $68.2M |
| FCF Margin % | 3.3% | 2.2% | 4.9% |
| Return on Invested Capital (ROIC %) | 4.6% | 8.3% | — |
| Cash & Short-Term Equivalents | $429.5M | $288.5M | — |
| Total Debt (Short + Long Term) | $990.9M | $425.3M | — |
| Total Stockholders' Equity | $779.3M | $712.7M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ASTH.